NCT02599194
- Conditions
- Adenocarcinoma, Adenoma, B-Cell Neoplasm, +53 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
Clinical trial condition
Triple Negative Breast Neoplasms
Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.
846 public trials
302 recruiting studies
Triple Negative Breast Neoplasms trial results
Completed
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer
NCT00733408
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
- Locations
-
- Anchorage Oncology Centre Anchorage, Alaska, United States
- Katmai Oncology Group Anchorage, Alaska, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Yuma Cancer Center Yuma, Arizona, United States
Completed
Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer
NCT00640861
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01986426
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
- Locations
-
- Jules Bordet Institute Brussels, Belgium
- Cliniques Universitaires St-Luc, Service d'oncologie médicale Brussels, Belgium
- Institut Curie Paris, France
- Institute Gustave Roussy Paris, France
NCT01031446
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Erlanger Cancer Center at Erlanger Hospital - Baroness Chattanooga, Tennessee, United States
- West Tennessee Cancer Center at Jackson-Madison County General Hospital Jackson, Tennessee, United States
- Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT02225470
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- 04 Eisai Trial Site Bengbu, Anhui, China
- 37 Eisai Trial Site Hefei, Anhui, China
- 01 Eisai Trial Site Beijing, Beijing Municipality, China
- 03 Eisai Trial Site Beijing, Beijing Municipality, China
NCT00986609
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
NCT00892736
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +48 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
NCT02485119
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenoma, +15 more
- Locations
-
- National Cancer Center Hospital East Kashiwa, Chiba, Japan
- National Cancer Center Hospital Tyuo, Japan
NCT03539965
- Conditions
- Breast Diseases, Breast Neoplasms, Disease Attributes, +10 more
- Locations
-
- Instituto Nacional do Cancer - CPQ Rio de Janeiro, Brazil